Sage Therapeutics Inc Asset Turnover Ratio (SAGE), as of second quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Sage Therapeutics Inc   (NASDAQ: SAGE)
 

Sage Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Sage Therapeutics Inc asset turnover ratio, the ability of Sage Therapeutics Inc 's assets to generate revenue in the second quarter 2025, increased sequentially to 0.14 in the second quarter (Jun 30 2025), yet the ratio remained below the average, as SAGE's position remain challenging.

Within sector 138 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2025 compared to the preceding quarter from 685 to 2663.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SAGE Asset Turnover Ratio (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Asset Change -40.58 % -39.9 % -38.74 % -35.17 % -35.21 %
Y / Y Revenue Change 265.84 % 77.97 % -83.56 % 337.08 % 249.8 %
Asset Turnover Ratio (TTM) 0.14 0.08 0.06 0.14 0.12
SAGE's Total Ranking # 2663 # 685 # 2405 # 3055 # 3107
Seq. Asset Change -10.09 % -14.47 % -11.99 % -12.2 % -9.06 %
Seq. Revenue Change 125.13 % 9.73 % 7.96 % 37.17 % 9.52 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 139
Healthcare Sector # 417
Overall Market # 2663

Asset Turnover Ratio Statistics
High Average Low
0.95 0.14 -0.11
(Dec 31 2020)   (March 31, 2014)




SAGE Company Profile • Back to SAGE Efficiency Comparisons • Compare SAGE Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2025 Assets at quarter ending Jun 30 2025
American Shared Hospital Services  0.47 $ 29.146  Millions$ 62.568  Millions
Boston Scientific Corporation  0.46 $ 18,494.000  Millions$ 39,793.000  Millions
Envista Holdings Corporation  0.46 $ 2,551.700  Millions$ 5,498.000  Millions
Staar Surgical Co  0.46 $ 224.449  Millions$ 485.565  Millions
Baxter International Inc   0.46 $ 10,887.000  Millions$ 23,702.000  Millions
Bio techne Corp  0.46 $ 1,219.272  Millions$ 2,660.503  Millions
Orthopediatrics Corp  0.46 $ 220.906  Millions$ 484.090  Millions
Pacira Biosciences inc   0.46 $ 705.848  Millions$ 1,549.785  Millions
Amphastar Pharmaceuticals Inc   0.46 $ 724.517  Millions$ 1,591.064  Millions
Lemaitre Vascular Inc   0.45 $ 234.162  Millions$ 515.610  Millions
Verona Pharma Plc  0.45 $ 221.673  Millions$ 488.717  Millions
Inmed Pharmaceuticals Inc  0.45 $ 4.943  Millions$ 10.957  Millions
Dyadic International Inc   0.45 $ 4.135  Millions$ 9.192  Millions
Glaukos Corp  0.45 $ 432.522  Millions$ 963.609  Millions
Anika Therapeutics Inc   0.44 $ 90.194  Millions$ 203.108  Millions
Ceribell Inc   0.44 $ 76.234  Millions$ 173.408  Millions
Nakamoto Inc   0.44 $ 2.240  Millions$ 5.114  Millions
Cvrx inc   0.44 $ 55.658  Millions$ 127.560  Millions
Enovis Corp  0.43 $ 2,187.360  Millions$ 5,041.338  Millions
Aquestive Therapeutics Inc   0.43 $ 44.132  Millions$ 101.828  Millions
Collegium Pharmaceutical Inc   0.43 $ 705.451  Millions$ 1,630.691  Millions
Ultragenyx Pharmaceutical Inc   0.43 $ 610.159  Millions$ 1,415.003  Millions
Biomarin Pharmaceutical Inc  0.43 $ 3,063.608  Millions$ 7,110.871  Millions
Sonida Senior Living Inc   0.43 $ 352.129  Millions$ 828.102  Millions
Perrigo Company Plc  0.43 $ 4,325.300  Millions$ 10,176.200  Millions
Abbvie Inc   0.42 $ 58,328.000  Millions$ 137,982.500  Millions
Quidelortho Corp  0.42 $ 2,741.600  Millions$ 6,516.350  Millions
Assertio Holdings inc   0.42 $ 117.097  Millions$ 280.234  Millions
Teleflex Incorporated  0.42 $ 3,040.611  Millions$ 7,280.679  Millions
Teva Pharmaceutical Industries Limited  0.42 $ 16,629.000  Millions$ 39,907.500  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.